Project Grant S10OD040097
- Federal Grant Award Summary Cornell University received a $750,000 project grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire an Orbitrap Astral mass spectrometer system interfaced with a Vanquish Neo ultra-high-performance liquid chromatography system from Thermo Fisher Scientific. The award, effective July 1, 2026 through June 30, 2027, supports the installation and operational setup of this...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $1.175M Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire a Bruker TIMSTOF Ultra 2 mass spectrometer for its Proteomics Core Facility. The award, obligated on May 18, 2026, with a completion date of May 17, 2027, will replace aging analytical equipment and significantly expand the institution's...
- Federal Project Grant Award Summary Yale University received a $1.98 million Project Grant from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) awarded on August 1, 2025, for the acquisition and installation of an Orbitrap Astral mass spectrometer system to support proteomics research through the Keck Mass Spectrometry & Proteomics Resource core facility. The Orbitrap Astral represents a state-of-the-art hybrid...
- Federal Project Grant Award Summary Award Details: The National Institutes of Health Office of the Director funded a $750,000 Project Grant to The Leland Stanford Junior University, effective August 1, 2025, through July 1, 2026, under the Research Infrastructure Programs (CFDA 93.351). The funding supports the acquisition and installation of a Bruker TimsTOF Flex MALDI-2 mass spectrometer at Stanford's Center for Genomics and Personalized Medicine Genome Sequencing Service Center. Products...
- Federal Grant Award Summary Dartmouth College received a $2.25 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, through August 31, 2029. The award supports the development of novel computational methods to decode disease mechanisms by reconstructing cellular proliferation, differentiation, and migration events from single-cell sequencing data. This...
- Federal Project Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded a $1 Project Grant to the University of California, Irvine on July 15, 2025, under the Research Infrastructure Programs (CFDA 93.351). The award funds the acquisition and installation of a refurbished Orbitrap Eclipse Tribrid mass spectrometer from Thermo Fisher Scientific, equipped with an Easy Electron Transfer Dissociation (ETD) option. This instrument provides advanced analytical...
- Federal Grant Award Summary The Leland Stanford Junior University received a $749,995 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) on June 15, 2026, with a completion date of June 14, 2027. The award supports the acquisition and installation of a Bruker timsTOF HT high-throughput mass spectrometry instrument at Stanford University Mass Spectrometry (SUMS), a shared research resource facility. This...
- Federal Grant Award Summary Dartmouth College received a $125,888 Project Grant from the National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems under the Engineering program (CFDA 47.041), effective July 1, 2025 through June 30, 2027. This collaborative research initiative supports the development of photonic-integrated-circuit two-photon (PIC-2P) microscopy technology designed to advance deep-tissue imaging capabilities. The primary...
- Federal Project Grant Award Summary Case Western Reserve University's Center for Proteomics and Bioinformatics received $1,557,366 in Project Grant funding from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire and operate an Orbitrap Astral mass spectrometer with ultra-high pressure liquid chromatography capabilities. The award, issued June 15, 2026, with a completion date of June 14, 2027, will establish this instrument...
- This Project Grant award of $348,724.00 from the U.S. Department of Health and Human Services National Institutes of Health (NIH), under the Research Infrastructure Programs (CFDA 93.351), will enable Auburn University to acquire a shared Agilent 6546 LC-QTOF (Liquid Chromatography-Quadrupole Time-of-Flight) mass spectrometer. This state-of-the-art instrument will replace an outdated 15-year-old mass spectrometer, significantly enhancing the university's biomedical research capabilities across a...
The National Institutes of Health (NIH) Office of the Director awarded Dartmouth College $1,260,425 under the Research Infrastructure Programs (CFDA 93.351) to acquire a Bruker TimsTOF Ultra 2 mass spectrometer system for the Dartmouth Proteomics Shared Resource. The award, made on June 15, 2026, with completion by June 14, 2027, funds the procurement and installation of high-performance analytical instrumentation designed to support the proteomics research capabilities of the greater Dartmouth biomedical research community. The equipment will be housed and maintained within the proteomics facility administered by the NCI-Designated Dartmouth Cancer Center on behalf of multiple departments and research centers across Dartmouth College and Dartmouth Medical School. The mass spectrometer will serve researchers conducting NIH-funded projects spanning basic cellular mechanisms and translational research, including investigations of cell cycle control, cancer metastasis, cellular translation in oncology, and neurodegenerative disease mechanisms. This infrastructure acquisition addresses the capacity limitations of Dartmouth's existing single LC-MS/MS platform and enables the completion of current and future research objectives for faculty across the Dartmouth Cancer Center, the Institute for Biomolecular Targeting, the Center for Quantitative Biology, and Dartmouth Synergy (a Clinical and Translational Science Award program).Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.3m | 6/9/26 |